جستجوی استاد راهنمای دانشگاهی

Dr. Merrina Anugraham is a Research Fellow at the Institute for Biomedicine and Glycomics , Griffith University, specializing in glycomics and glycoproteomics research with a focus on cancer biology. Her work bridges biomedical sciences and proteomics, particularly in ovarian cancer and glycan-based tumor signatures. Appointments : Griffith University (2024–present) Research Focus : Glycomics, cancer-associated glycosylation, and glycoprotein analysis Research Trends : Her publications highlight glycosylation defects in cancer, including N-glycosylation patterns in tumors, glycolipid roles in ovarian cancer migration, and epigenetic influences on glycan structures. Methodologies emphasize mass spectrometry and structural characterization of glycans. Grants : Internal funding from Griffith University for Decoding the Effects of Vaccination against Neisseria gonorrhoeae using IgG glycocodes (2023–2024) Collaborations : Extensive co-authorship networks in glycomics, oncology, and proteomics Publications : 8 research outputs (2014–2019) focusing on glycan alterations in cancer, with high citation impact in tumor glycobiology

• Glycomics
• Glycoproteomics
• Cancer Biology
• +۵ مورد دیگر

Associate Professor Bernadette Saunders is a cellular immunologist specializing in infectious diseases at the University of Technology, Sydney (UTS), School of Life Sciences. She holds dual roles as an Associate Professor and Director of Postgraduate Coursework Programs within the Faculty of Science. Her research focuses on host immunity, inflammation control, and developing diagnostics/therapies for mycobacterial diseases (including TB and M. avium), Lymphangioleiomyomatosis (LAM), and Alzheimer’s vaccines. She leads projects on biomarker discovery, macrophage function, microRNA regulation, organoid models, and nanocage vaccine technology. Education and Training: Saunders trained at the University of Melbourne, completed postdoctoral studies at Colorado State University and the Centenary Institute, and joined UTS in 2015. Research Interests: Her work spans Novel biomarkers for TB diagnosis and treatment monitoring Macrophage mechanisms in infection control Mycobacterial therapy development MicroRNA roles in immunity and inflammation Organoid models for LAM and TB Nanocage-based vaccines Grants and Collaborations: Her funded projects include NIH-supported vaccine adjuvant research, NHMRC grants on miRNA therapies, and Dementia Australia-funded Alzheimer’s vaccine development. Collaborations involve UTS teams and international partners in virology and microbiology. Labs and Teams: Saunders’ group develops organoid models and tests novel therapies, particularly for LAM and mycobacterial infections. She actively collaborates on nanotechnology-based vaccine platforms.

• Infectious Disease Immunology
• Macrophage Biology
• Mycobacterial Pathogenesis
• +۳ مورد دیگر

Nicki Packer is Professor at Griffith University's Institute for Biomedicine and Glycomics. Her research expertise spans glycobiology, proteomics, and analytical chemistry with applications in cardiovascular disease, immunology, and metabolic disorders. Research focuses on: Glycan-protein interactions in immune regulation Glycan-based diagnostic tools Extracellular matrix biology Cardiovascular glycobiology Publications demonstrate methodological innovations in glycoanalytics (45%), glycoprotein functions (30%), and consortium reports (15%). Notable contributions include development of SSSMuG for multi-glycomic analysis and lectin-based SERS nanotags. She contributes to major collaborative initiatives including the HUPO Human Proteome Project and leads research on ASGR1 receptor's role in atherosclerosis.

• Glycobiology
• Glycomics
• Biochemistry
• +۲ مورد دیگر

Dr. Rebecca Roubin is a Lecturer in the Department of Pharmaceutical and Medicinal Chemistry at the University of Sydney's Faculty of Pharmacy. She holds a BSc (Hons) from UNSW and a PhD. Her research focuses on molecular mechanisms of the tumor microenvironment, particularly in blood cancers like Multiple Myeloma, alongside exploring synergistic nuclear receptor agonists and traditional Chinese medicine (TCM) applications. Collaborations include work with Hong Kong Polytechnic University on PPARγ pathways and immunomodulatory glycoproteins. Her research themes include Cancer, Cardiovascular/ Diabetes, and Health Services. She has published widely on topics ranging from PPAR agonist design to ethnobotanical drug discovery. Key grants include projects on PPARγ agonists (2006) and glycoproteomic diagnostics (2003). She also contributes to pharmacy education and anti-doping practices in athlete care. Education: BSc (Hons) UNSW, PhD International Collaborations: Hong Kong Polytechnic University, Shanxi University (China) Grants: 4 major grants including PPARγ therapy and cartilage gene therapy Labs/Teams: Cancer Immunotherapy Group, TCM Anticancer Research Unit Her work bridges basic science and translational medicine, emphasizing drug development for hard-to-treat cancers and leveraging traditional medicinal knowledge.

• Cancer Research
• Pharmacology
• Medicinal Chemistry
• +۳ مورد دیگر

Daniel Kolarich is Professor and ARC Future Fellow at Griffith University's School of Environment and Science, Department of Chemistry and Forensic Science. He leads the cancer glycomics initiative at the Australian Centre for Cancer Glycomics and the Advanced Mass Spectrometry Facility at the Institute for Glycomics. His academic background includes a PhD from the University of Natural Resources and Life Sciences Vienna, habilitation at Freie Universität Berlin, and postdoctoral positions at Macquarie University and Max Planck Institute. Kolarich's research focuses on glycosylation in cancer biology, developing glycan-sequencing technologies for clinical applications. His work has pioneered sequencing from as few as 1000 cells, enabling comprehensive glycosylation mapping in ovarian, breast, prostate, and other cancers. Research interests include glycoproteomics, viral-host interactions, and receptor tyrosine kinase glycosylation. His publications predominantly explore glycoproteomic informatics, cancer glycobiology, and HIV assembly mechanisms. Recent work reveals structural aspects of viral particle formation and glycan-mediated host-pathogen interactions. Kolarich has supervised 13 doctoral students to completion and leads current projects on novel diagnostics and Pseudomonas aeruginosa treatment. Awards include an ARC Future Fellowship, Marie Curie Integration Grant, and Sanofi-Aventis Prize. He serves as Editor-in-Chief of the Glycoconjugate Journal. His laboratory develops spatial transcriptomics and light sheet fluorescence microscopy techniques. International collaborations focus on translating glycomic discoveries into precision medicine applications for early cancer detection.

• Glycoproteomics
• Cancer Glycomics
• Mass Spectrometry
• +۳ مورد دیگر

Dr. Nick DeBono is a Research Fellow at the Institute for Biomedicine and Glycomics at Griffith University since 2024, having previously been affiliated with the Institute for Glycomics from 2017-2024. He completed his PhD at Macquarie University in August 2024 with ORCID identifier 0000-0001-5452-3008. His research specializes in glycoproteomics, proteomics, and released glycomics analysis using mass spectrometry techniques. His work bridges analytical chemistry with biological applications, particularly focused on understanding glycan structures and their functional roles in immunological processes and disease mechanisms. He has developed innovative methodologies for glycan and glycopeptide analysis that advance the field of glycobiology. Dr. DeBono's publication record demonstrates consistent contributions to high-impact journals, with recent work focusing on the molecular basis of immunosuppression through glycan interactions (2025), experimental methods for identifying peptide glycotopes (2024), and novel approaches for multi-glycomics analysis from single samples (2024). His research shows an evolving trajectory from bacterial pattern formation (2016) to increasingly sophisticated glycomics and proteomics applications. His collaborative approach is evident in his numerous co-authorships across multiple research groups, particularly with colleagues at Griffith University's Institute for Biomedicine and Glycomics. While specific teaching responsibilities aren't detailed in the available information, his role as Research Fellow indicates a primary focus on advancing scientific knowledge in glycobiology through experimental and analytical approaches.

• Glycomics
• Proteomics
• Glycoproteomics
• +۲ مورد دیگر

Dr. Rebeca Kawahara Sakuma is an Honorary Research Fellow at Macquarie University's Department of Molecular Sciences within the School of Natural Sciences. She holds a Cancer Institute NSW Early Career Fellowship (2019-2022) and focuses on understanding protein N-glycosylation's role in colorectal cancer's tumor microenvironment and immune processes. Her research integrates glycoimmunology, molecular cancer biology, and glycobiology. Education: PhD in Functional and Molecular Biology (University of Campinas, Brazil, 2015), followed by postdoctoral research at the University of São Paulo (2015-2017) and Macquarie University (2017-2018). Research Interests : Glycosylation in cancer progression, tumor-immune interactions, and biomarker discovery. Key projects include: "Colorectal Cancer Glycobiology: Unexpected Players in Epithelial-Mesenchymal Transition and Inflammation" (2019-2022) "Deciphering the 'Sugar-Code' of Colorectal Cancer" (2019-2021) Research Trends : Recent work emphasizes enzyme-driven glycosylation changes (e.g., HEXB, N-acetyl-β-D-hexosaminidase) in cancer progression and patient stratification. Techniques include glycoproteomics and proteomics to profile tumor microenvironments. Awards : Cancer Institute NSW Early Career Fellowship (2019-2022). Grants & Projects : Led/co-investigator on two projects focusing on glycobiology and colorectal cancer mechanisms, funded by Macquarie University and external bodies. Labs/Teams : Active in the Glycoimmunology group led by Dr. Morten Thaysen-Andersen, collaborating on glycoproteomic profiling and cancer biomarker research.

• Glycoimmunology
• Colorectal Cancer
• Protein N-Glycosylation
• +۴ مورد دیگر

Georgy Sofronov is an Associate Professor in Statistics and Director of Research Training at Macquarie University's School of Mathematical and Physical Sciences. He holds a PhD in Probability Theory and Mathematical Statistics from Moscow State University (2002). Previously, he held academic positions at the University of Queensland and the University of Wollongong. He serves on editorial boards for Statistical Papers and Methodology and Computing in Applied Probability , and is Treasurer of the Modelling and Simulation Society of Australia and New Zealand. His research focuses on change-point detection, statistical quality control, optimal decision rules, and computational statistics. Research Interests : Change-point problem, statistical quality control Optimal decision rules, operations research Markov chain Monte Carlo methods, Cross-Entropy method Statistical modelling and data analysis Statistical Software (R-package 'breakpoint') Affiliations : Biomolecular Discovery Research Centre Centre for Risk Analytics Data Horizons Research Centre Smart Green Cities Research Centre Transforming Energy Markets Research Centre Teaching : Courses include Statistical Theory , Probability , Market Research and Forecasting , and Statistical Inference . Grants & Projects : SmartCrete CRC (2020–2027) Multiple change-point detection methods for big data (2017–present) Awards : Learning and Teaching Award (2016) Award for Excellence in HDR Supervision (2021) Collaborations : Active in Australia, New Zealand, and international networks focusing on computational statistics and risk analytics.

• Statistical Analysis
• Operations Research
• Change-Point Detection
• +۶ مورد دیگر

Liisa Kautto is a Senior Research Fellow at Macquarie University's School of Natural Sciences with an h-index of 14 and 489 citations across 30 research outputs. Her work bridges biochemistry, microbiology, and medical research with a focus on glycosylation patterns and their implications in disease. Institution: Macquarie University, School of Natural Sciences Research Focus: Glycomics, Microbiology, Cancer Glycobiology Active Projects: Biomolecular Discovery and Design Research Centre (2017-present) Dr. Kautto's research interests center on glycomics and its applications in understanding disease mechanisms. Her work spans fungal pathogenesis, particularly with Scedosporium aurantiacum , and the role of glycosylation in colorectal cancer development and progression. She investigates how specific enzymes like HEXB affect glycosylation patterns in cancer cells and how dietary factors influence mucin glycosylation in the gut microbiome. Her fingerprint analysis shows strong expertise in glycomics (49%), polysaccharide research (81%), and fungal pathogens including Scedosporium (100%) and Trichoderma reesei (66%). Her recent publications (2019-2025) demonstrate a clear trajectory toward understanding the connection between glycosylation abnormalities and disease states, particularly in cancer. The most recent work focuses on how HEXB-driven paucimannosylation can stratify colorectal cancer patient risk, representing a potential diagnostic and therapeutic target. Her methodological contribution with SSSMuG (Same Sample Sequential Multi-Glycomics) provides a valuable tool for comprehensive glycan analysis. Glycomics: 49% of research fingerprint Polysaccharide Research: 81% of research fingerprint Fungal Pathogen Studies: 100% Scedosporium focus Cancer Glycobiology: Major focus in recent publications Dr. Kautto has maintained consistent research productivity with publications spanning from 2004 to the present, including several high-impact publications in 2024-2025. She collaborates extensively with researchers including Packer, Nevalainen, Molloy, and Paulsen across multiple projects. Her work on the Biomolecular Discovery and Design Research Centre (active since 2017) continues her earlier involvement with the Biomolecular Frontiers Research Centre (2006-2015), demonstrating long-term commitment to biomolecular research at Macquarie University.

• Glycomics
• Microbiology
• Infectious Diseases
• +۵ مورد دیگر

Kevin Chau is affiliated with the School of Natural Sciences and Faculty of Science and Engineering at Macquarie University, holding a Doctor of Philosophy. His research focuses on glycomics, proteomics, and their biomedical applications. Key areas include glycoproteomics, proteome analysis, and their roles in health and disease. Recent work addresses topics such as N-glycoproteomics, platelet proteome characterization, septic shock biomarkers, tumor microenvironment profiling, and colorectal cancer mechanisms. His contributions span collaborative studies with global researchers, emphasizing open-access publishing and impactful methodologies. With an h-index of 53, his research has garnered significant citations across disciplines.

• Glycomics
• Proteomics
• Biomedical Research
• +۳ مورد دیگر

Dr. Edward Moh is a Research Fellow at the School of Natural Sciences , Macquarie University. His research focuses on glycomics , glycosylation , and protein chemistry , with applications in neurodegenerative diseases and diabetes . Active projects include NHMRC-funded research on reversing neurofibrosis for diabetes treatment and glycoproteomic studies in ALS/FTD. His work combines biophotonics with molecular biology , resulting in high-impact publications in Nature Communications , Journal of Biological Chemistry , and Analyst . He received the Faculty of Science and Engineering Award for Higher Degree Research in 2017. Recent publications highlight trends in glycan analysis , diagnostic ion discovery , and nanotag development , supported by collaborations in synthetic biology and mitochondrial research . Key scientific awards: Faculty of Science and Engineering Award for Higher Degree Research (2017) .

• Glycomics
• Glycosylation
• Polysaccharides
• +۹ مورد دیگر

Prof Nicki Packer is a Distinguished Professor and Deputy Director of the Biomolecular Discovery Research Centre at Macquarie University. She also serves as Academic Lead of the Australian Proteome Analysis Facility (APAF) and is a Chief Investigator in multiple ARC Centres of Excellence. Her research focuses on glycomics' role in health and disease, including cancer, infections, and cardiovascular disorders. Education: PhD in Biochemistry, University of Sydney (1973–1977) Research Interests: Prof Packer's work explores glycans' structural and functional roles in biological processes, particularly their implications for cancer, therapeutics, and microbial infections. Key areas include glycoproteomics, glycobiology's integration with proteomics, and glycan applications as molecular markers. Recent Research Trends: Recent publications highlight advancements in vaccine development using Salmonella vectors, enzymatic inhibition mechanisms, and glycobiology's role in cardiovascular disease and immunology. These studies underscore her interdisciplinary approach linking basic science to clinical applications. Grants & Projects: A Prelude towards transforming adenoid cystic carcinoma into an immune hot tumour (2025–2026) Deep milk: multi-omics study on type 1 diabetes risk (2024–2025) Metformin's role in colorectal cancer prevention (2023–2026) Labs & Affiliations: She leads teams at the Biomolecular Discovery Research Centre and APAF, collaborating internationally through networks like the GlySpace Alliance.

• Glycomics
• Glycoproteomics
• Biochemistry
• +۳ مورد دیگر

Associate Professor Morten Thaysen-Andersen leads the Analytical Glycoimmunology group at Macquarie University's School of Natural Sciences. His research focuses on advancing understanding of the human innate immune system through glycomics and glycoproteomics technologies, leveraging mass spectrometry and multidisciplinary approaches. He is an ARC Future Fellow and directs the ARC Training Centre for Facilitated Advancement of Australia's Bioactives (FAAB). His work addresses microbial infections, inflammation, and cancer by elucidating glycobiological mechanisms in immune-related diseases. Research interests include N-glycan analysis, tumor microenvironment profiling, immune cell glycosylation dynamics, and septic shock pathogenesis. He collaborates on projects like high-content oncoproteomics and cystic fibrosis immune cell studies. Key awards include the ARC Future Fellowship (2022–2027). His lab develops glycan-based biomarkers and investigates glycoprotein function in health and disease. Key Projects: FAAB Training Centre (2022–2027) High-Content Oncoproteomics (2017–present) Neutrophil Glycosylation in Cystic Fibrosis (2017–present) Labs: Analytical Glycoimmunology Group Biomolecular Discovery Research Centre Grants & Awards: ARC Future Fellowship (2022–2027) Multiple project grants from NHMRC and industry partners His work bridges analytical chemistry with clinical applications, contributing to diagnostics and therapeutics in immunology and oncology. Collaborations span microbiology, structural biology, and systems biology.

• Glycomics
• Glycoproteomics
• Immunology
• +۷ مورد دیگر

Dr. Charlie Ahn is a Research Fellow at the Macquarie Medical School, Macquarie University. His research focuses on proteomics, cancer biomarker discovery, and molecular mechanisms of colorectal and breast cancers. He leads and collaborates on projects such as 'Protein Biosignatures for Predicting Colorectal Cancer Recurrence' and 'uPAR Peptide Therapeutics for Cancer Metastasis'. Active projects: Biomolecular Discovery and Design Research Centre (2017–), Next Generation Colorectal Cancer Biomarkers (2016–) Research interests: Proteomic analysis of cancer progression, extracellular vesicles, and kynurenine pathway proteins His work employs advanced mass spectrometry and spectral library techniques, contributing to over 45 peer-reviewed publications. Key collaborations include work on microglial cell lines and metastasis-associated enzymes. Notable contributions include identifying HEXB-driven glycoproteomic changes in colorectal cancer and developing methods for low-abundance protein quantification.

• Proteomics
• Colorectal Cancer
• Biomarker Discovery
• +۳ مورد دیگر

Anthony Purcell is a Research Professor in Biochemistry & Molecular Biology at Monash University, affiliated with the Monash Biomedicine Discovery Institute. He holds a Visiting Professorship at the University of Southampton (2016–2019) and serves as Councillor of the Human Proteome Organization (2017–2023). His research focuses on quantitative proteomics, immune response targets, and host-pathogen interactions. Key areas include cancer immunology, autoimmunity (e.g., diabetes, psoriasis), antigen processing, vaccine design, and bioinformatics. Purcell has led or contributed to 54 research projects and over 336 publications, including high-impact journals like Nature and Nature Immunology. He is an editorial board member for Molecular & Cellular Proteomics and Molecular Immunology. Notable contributions include developing immunopeptidomics tools and identifying novel therapeutic targets in cancer and autoimmune diseases. His lab collaborates globally and contributes to UN Sustainable Development Goals. Research Interests Quantitative proteomics of complex biological samples Immunopeptidome analysis for antigen discovery Autoimmunity mechanisms (e.g., type 1 diabetes, psoriasis) Cancer immunotherapy targets Vaccine design (influenza, cancer) Recent Research Output Recent studies highlight advances in immunopeptidomics, including identification of tumor antigens, psoriasis triggers, and influenza epitopes. Collaborations span structural biology, bioinformatics, and clinical translation. Grants & Collaborations Active projects include non-canonical influenza immunity, type 1 diabetes epitopes, breast cancer vaccine targets, and psoriasis antigen triggers. Purcell’s work has attracted global attention, including media coverage of superbug research funded by A$9.8 million grants. Labs & Teams Leads the Purcell Lab at Monash, focusing on integrating proteomics with immunology and structural biology to address immune-related questions.

• Immunology
• Proteomics
• Autoimmunity
• +۴ مورد دیگر